Abstract
Personalized medicine is revolutionizing the delivery of oncological care, promising benefits both at the patient and health system levels. The cost of targeted therapies, unfortunately, is becoming more expensive and unaffordable. Where supportive care in cancer concerns the prevention and management of the adverse effects of cancer and its treatment and is the thrust of the Multinational Association of Supportive Care in Cancer, financing of and value in personalized medicine is an important area of research and engagement for the association. Discussing patients’ concerns with and identifying those at most risk for the financial hazard of cancer treatment and offering financial counseling and assistance and/or referral to support networks are potential key areas for (exploring and providing) better supportive care. The time is now to turn the concern of patients and their carers, providers, and other advocates regarding the affordability of cancer treatment into a collective cause towards coordinated action.
| Original language | English |
|---|---|
| Pages (from-to) | 3399-3401 |
| Number of pages | 3 |
| Journal | Supportive care in cancer |
| Volume | 23 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 27 Aug 2015 |
Keywords
- METIS-311329
- IR-96896
